EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro antibiofilm efficacy of ertapenem, tobramycin, and moxifloxacin against biofilms grown in a glass bead or CDC Biofilm Reactor®

Annika L Gilmore iD, Helena Vu, Travis Martinez iD, Lousili Peniata, Brooke Kawaguchi, David A Armbruster, Nicholas N Ashton, Dustin L Williams

PLOS ONE · 10.02.2025 · 20 (2) · e0318487

DOI: 10.1371/journal.pone.0318487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 10.02.2025. Verfasst von Annika L Gilmore und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah, United States of America. Hauptthemen laut MEDLINE: Biofilms, Tobramycin, Anti-Bacterial Agents, Fluoroquinolones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CDMRP, Congressionally Directed Medical Research Programs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Laboratory grown biofilms are used to simulate bacterial growth in diverse environmental conditions and screen the effectiveness of anti-biofilm therapies. Recently, we developed a glass bead biofilm reactor that utilizes low broth volume to provide high-throughput biofilm growth for testing and translation across the research continuum (e.g., benchtop assays to preclinical models). Bioburden per mm 2 surface area of Staphylococcus aureus and Pseudomonas aeruginosa biofilms were comparable on beads and CDC Biofilm Reactor® coupons. In this study, we hypothesized that biofilms grown on beads would be more susceptible to ertapenem, moxifloxacin, and tobramycin than those grown on coupons. Results indicated a significant reduction in S. aureus bioburden on glass beads compared to glass coupons following treatment with ertapenem ( p = 0.005) and tobramycin ( p = 0.014). P. aeruginosa biofilms had smaller differences in antibiotic response between the two systems. There was a significantly greater reduction in bead P. aeruginosa biofilm than coupon when treated with tobramycin ( p = 0.035). This work offered insight into how the bead biofilm reactor could be used as a tool for antibiotic screening and translation across the continuum of in vitro to in vivo systems that support development of antimicrobial technology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsTobramycinAnti-Bacterial AgentsFluoroquinolonesBioreactorsPseudomonas aeruginosaMoxifloxacinStaphylococcus aureusErtapenemMicrobial Sensitivity TestsGlass

Substanzen

TobramycinAnti-Bacterial AgentsMoxifloxacinErtapenemFluoroquinolones

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah, United States of America.
  • Department of Orthopaedics, University of Utah, Salt Lake City, Utah, United States of America.
  • Bone and Biofilm Research Lab, University of Utah, Salt Lake City, Utah, United States of America.
  • Depuy Synthes, West Chester, Pennsylvania, United States of America.
  • Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
  • Department of Physical Medicine and Rehabilitation, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.

ORCID-Profile: Annika L Gilmore, Travis Martinez

Förderung

  • CDMRP
  • Congressionally Directed Medical Research Programs

Zitieren

APA

Gilmore, A. L., Vu, H., Martinez, T., Peniata, L., Kawaguchi, B., Armbruster, D. A., Ashton, N. N., & Williams, D. L. (2025). In vitro antibiofilm efficacy of ertapenem, tobramycin, and moxifloxacin against biofilms grown in a glass bead or CDC Biofilm Reactor®. PLOS ONE, 20(2), e0318487. https://doi.org/10.1371/journal.pone.0318487

Vancouver

Gilmore AL, Vu H, Martinez T, Peniata L, Kawaguchi B, Armbruster DA, et al. In vitro antibiofilm efficacy of ertapenem, tobramycin, and moxifloxacin against biofilms grown in a glass bead or CDC Biofilm Reactor®. PLOS ONE. 2025;20(2):e0318487. doi:10.1371/journal.pone.0318487

BibTeX
@article{Gilmore2025,
  author = {Gilmore, Annika L and Vu, Helena and Martinez, Travis and Peniata, Lousili and Kawaguchi, Brooke and Armbruster, David A and Ashton, Nicholas N and Williams, Dustin L},
  title = {In vitro antibiofilm efficacy of ertapenem, tobramycin, and moxifloxacin against biofilms grown in a glass bead or CDC Biofilm Reactor®},
  journal = {PLOS ONE},
  year = {2025},
  volume = {20},
  number = {2},
  pages = {e0318487},
  doi = {10.1371/journal.pone.0318487}
}
Kostenlos starten →